The magazine of the German Centers for Health Research (DZG) SYNERGIE has won the silver award Berliner Type. The Berliner Type competition honors the best print products from Germany, Austria and…
The development of therapy resistance often prevents advanced colorectal cancer from being successfully treated in the long term. Scientists from the German Cancer Consortium (DKTK), partner site at…
Researcher at the Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy and the University of Lausanne developed a novel combination therapy that prevents the acquisition of adaptive…
The right therapy for the right patient group at the right time - that is what precision medicine makes possible. In the current issue of the DZG magazine SYNERGIE, the German Centers for Health…
In the DKTK online seminar series of the School of Oncology on techniques of translational research, Pia Hönscheid, coordinator of the MALDI Imaging Unit at NCT Dresden, introduced herself and…
The biochemist Katalin Karikó (66), the physician Özlem Türeci (54) and the physician Uğur Şahin (56) are the recipients of the Paul Ehrlich and Ludwig Darmstaedter Prize 2022. Today, this was…
Throughout the world, more men than women develop colorectal cancer. Scientists from the German Cancer Research Center have now analyzed the extent to which known and presumed risk and protective…
Cancer researchers have discovered a mechanism that can activate the self-destruction of cancer cells of childhood tumors: A drug combination already being tested in other cancers caused the cancer…
Christiane Opitz, scientist at the German Cancer Research Center, is being awarded this year's Ita Askonas Prize of the European Federation of Immunological Societies. Opitz has discovered how tumor…
Each tumor consists of multiple cell types, all of which have distinct characteristics. In addition to determining the course of the disease, these differences between individual cancer cells control…
Colorectal cancer is the second most common tumor disease among women and the third most common among men in Germany. Intestinal tumors often form dangerous metastases in other organs. A team of…
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium (DKTK), the Technical University of Munich (TUM), and the…
For the first time, scientists from the German Cancer Consortium (DKTK) partner site in Essen/Düsseldorf have discovered stem cells of the hematopoietic system in glioblastomas, the most aggressive…
Joint press release of Charité and the BIH together with the MDC Researchers at the Charité – Universitätsmedizin Berlin, Max Delbrück Center for Molecular Medicine in the Helmholtz Association…
Jakob Nikolas Kather conducts research in the newly established field of computer-based methods in clinical imaging. The results of his work help further develop the evaluation and interpretation of…
This time, the DKTK seminar series on translational research techniques for young scientists was dedicated to the question: "How can I improve my group leadership and teamwork skills at the same…
What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of…
April 13th, 2021: Fighting common diseases together! The mission of the German Centers for Health Research (DZGs) is to optimize the translation of research results to their application in patients…
Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated…